cpg 7909 oligodeoxynucleotide
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2005 (NCT00344539)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Toll-like receptor 9AGONIST
TLR9 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 1018 iss immunostimulatory oligonucleotide
- cpg 7909 oligodeoxynucleotide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00403052 | Phase 1 | Nov 1, 2006 | Dynavax Technologies Corporation |
| NCT00426712 | Phase 1 | Jan 1, 2006 | Dynavax Technologies Corporation |
| NCT00344539 | Phase 1 | May 1, 2005 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dynavax Technologies Corporation | For profit | 2 | 2 | 1 | 2006 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2005 |
2 organizations
Page 1 / 1